Clinical trials · Austin, TX
Parkinson’s disease clinical trials in Austin
We’re tracking 12 recruiting parkinson’s disease studies with a site in or near Austin — including Phase 1, Phase 2, Phase 2/Phase 3, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies near Austin
- NCT06565195RecruitingPhase 1
Study of an investigational drug for Parkinson's disease
This study tests an experimental drug called LY3962681 in two groups: healthy volunteers and people with Parkinson's disease. The goal is to see if the drug is safe and how the body handles it, which may lead to future treatments for Parkinson's.
Austin, TexasAges 30–80 - NCT06809400RecruitingPhase 1
Study of LY4006896 for Parkinson's disease
This study tests an investigational drug called LY4006896 in healthy people and in people with Parkinson's disease. It aims to see if the drug is safe and how it affects the body, which may help in developing a new treatment for Parkinson's.
Austin, TexasAges 30–85 - NCT07284784RecruitingPhase 2/Phase 3
Buntanetap for Parkinson's disease study
This trial tests an investigational drug called buntanetap in people with Parkinson's disease. It aims to see if the drug can improve symptoms. There are two groups: those who've taken buntanetap before (Cohort 1) and those with a deep brain stimulator (DBS) implant for at least a year (Cohort 2).
Round Rock, TexasAges 40–85 - NCT07514858RecruitingPhase 2
Lu AF28996 for Parkinson's Disease Motor Fluctuations
This trial tests a new medication called Lu AF28996 to help reduce the periods when Parkinson's symptoms worsen throughout the day (called 'OFF times'). If you have motor fluctuations that are predictable and affecting your daily life, this study might help you experience fewer of these difficult periods.
Round Rock, TexasAges 40–85 - NCT06680830RecruitingPhase 2
Testing NEU-411 for early Parkinson's with LRRK2 gene change
This trial tests an experimental drug called NEU-411 for people with early Parkinson's disease who have a specific genetic change (LRRK2). It aims to see if the drug can slow the disease progression.
Round Rock, TexasAges 40–80 - NCT07804615RecruitingPhase 2
Investigational drug for tremor from Parkinson's disease
This study is testing an investigational drug for Parkinson's-related tremor (shaking). It aims to see if the drug can help reduce tremor in people whose symptoms are not fully controlled by current treatment.
Round Rock, TexasAges 18–65 - NCT07432958RecruitingPhase 2
Study of AP-472 with levodopa for Parkinson's motor fluctuations
This trial tests an experimental drug called AP-472, taken alongside your regular Parkinson's medications, to see if it can reduce the amount of "OFF" time you experience each day when symptoms return between doses of levodopa.
Round Rock, TexasAges 30–80 - NCT07174310RecruitingPhase 3
Prasinezumab for early Parkinson's disease
This study tests a new medication called prasinezumab, given through a vein (IV), to see if it can slow the progression of early-stage Parkinson's disease. It is for people who are on only one Parkinson's medication and have not yet developed motor complications.
Round Rock, TexasAges 50–85 - NCT06976268RecruitingPhase 2/Phase 3
Testing BHV-8000 for early Parkinson's disease
This study tests a new once-daily pill called BHV-8000 in people who were recently diagnosed with early Parkinson's disease and are not yet on medication. The goal is to see if it can slow the progression of symptoms and improve quality of life.
Round Rock, TexasAges 40–80 - NCT04071847Recruiting
Study tracking results after Abbott deep brain stimulator surgery
This study follows people who are getting a new Abbott deep brain stimulator (DBS) device or replacing the battery/implantable pulse generator to see how outcomes change over time. It mainly applies to certain DBS targets and diagnoses, and it uses follow-up visits to track results.
Georgetown, TexasAges Any age - NCT07227896Recruiting
Study of a new pump treatment for advanced Parkinson's
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
Georgetown, TexasAges 18–80 - NCT06765668RecruitingPhase 4
Study of CREXONT for Parkinson's with wearing-off episodes
This study tests how well CREXONT, an extended-release form of carbidopa-levodopa, controls symptoms in people with Parkinson's who experience predictable 'off' periods when their regular medication wears off. The goal is to see if it can reduce the daily hours of poor mobility.
Georgetown, TexasAges 18 years+
Hear when a new Parkinson’s disease trial opens near Austin, TX
We’ll email you when one opens near Austin, TX — at most once a week, no account needed, unsubscribe anytime.
Parkinson’s disease trials in other cities
Where these studies are running near Austin
Institutions with a site for the recruiting parkinson’s disease studies listed above.
- Central Texas Neurology Consultants · 3 studies
- PPD Austin Clinical Research Unit · 2 studies
- Central Texas Neurology
- Central Texas Neurology Consultants (CTNC)
- Site-043
- Texas Movement Disorder Specialist
- Texas Movement Disorder Specialists /ID# 278565
- Texas Movement Disorder Specialists, PLLC
What taking part in a parkinson’s disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting parkinson’s disease studies in Texas.
Common questions
- Are there parkinson’s disease clinical trials near Austin?
- Yes. We're currently tracking 12 recruiting parkinson’s disease studies with a site near Austin, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a parkinson’s disease study near Austin?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Austin to take part?
- Not necessarily. These studies have a site near Austin, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a parkinson’s disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New parkinson’s disease studies open near Austin regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.